Vertex Pharmaceuticals Incorporated (VX1.DE)

EUR 446.45

(-0.18%)

Net Debt Summary of Vertex Pharmaceuticals Incorporated

  • Vertex Pharmaceuticals Incorporated's latest annual net debt in 2023 was -9.56 Billion USD , up 3.84% from previous year.
  • Vertex Pharmaceuticals Incorporated's latest quarterly net debt in 2024 Q2 was -3.64 Billion USD , up 56.78% from previous quarter.
  • Vertex Pharmaceuticals Incorporated reported annual net debt of -9.94 Billion USD in 2022, down -59.39% from previous year.
  • Vertex Pharmaceuticals Incorporated reported annual net debt of -6.23 Billion USD in 2021, down -15.38% from previous year.
  • Vertex Pharmaceuticals Incorporated reported quarterly net debt of -8.43 Billion USD for 2024 Q1, up 11.76% from previous quarter.
  • Vertex Pharmaceuticals Incorporated reported quarterly net debt of -9.56 Billion USD for 2023 Q4, down -741.92% from previous quarter.

Annual Net Debt Chart of Vertex Pharmaceuticals Incorporated (2023 - 1990)

Historical Annual Net Debt of Vertex Pharmaceuticals Incorporated (2023 - 1990)

Year Net Debt Net Debt Growth
2023 -9.56 Billion USD 3.84%
2022 -9.94 Billion USD -59.39%
2021 -6.23 Billion USD -15.38%
2020 -5.4 Billion USD -113.54%
2019 -2.53 Billion USD -21.55%
2018 -2.08 Billion USD -89.1%
2017 -1.1 Billion USD -218.63%
2016 -345.69 Million USD -426.6%
2015 105.84 Million USD -47.09%
2014 200.03 Million USD 255.84%
2013 -128.36 Million USD -170.06%
2012 183.22 Million USD 343.26%
2011 -75.32 Million USD -125.64%
2010 293.79 Million USD 200.33%
2009 -292.82 Million USD -188.17%
2008 -101.61 Million USD 69.73%
2007 -335.66 Million USD -275.4%
2006 -89.41 Million USD -187.62%
2005 102.05 Million USD -63.55%
2004 279.99 Million USD 13.25%
2003 247.22 Million USD 12.36%
2002 220.04 Million USD 58.99%
2001 138.4 Million USD 401.45%
2000 27.6 Million USD 213.11%
1999 -24.4 Million USD -69.44%
1998 -14.4 Million USD 77.18%
1997 -63.1 Million USD -139.02%
1996 -26.4 Million USD -23.36%
1995 -21.4 Million USD 67.18%
1994 -65.2 Million USD -188.5%
1993 -22.6 Million USD -247.69%
1992 -6.5 Million USD 73.25%
1991 -24.3 Million USD -1925.0%
1990 -1.2 Million USD 0.0%

Peer Net Debt Comparison of Vertex Pharmaceuticals Incorporated

Name Net Debt Net Debt Difference
BioNTech SE -11.44 Billion EUR 16.461%
CureVac N.V. -360.92 Million EUR -2548.941%
Biotest Aktiengesellschaft 571.3 Million EUR 1773.499%
Biotest Aktiengesellschaft 571.3 Million EUR 1773.499%
BRAIN Biotech AG -693 Thousand EUR -1379510.39%
Formycon AG 2.45 Million EUR 390173.439%
Heidelberg Pharma AG -37.6 Million EUR -25322.293%
Medigene AG -5.72 Million EUR -166928.302%